Kimia Biosciences Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 332.24 million compared to INR 343.48 million a year ago. Revenue was INR 334.42 million compared to INR 349.02 million a year ago. Net loss was INR 13.45 million compared to net income of INR 4.27 million a year ago. Basic loss per share from continuing operations was INR 0.28 compared to basic earnings per share from continuing operations of INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 0.28 compared to diluted earnings per share from continuing operations of INR 0.09 a year ago.
For the nine months, sales was INR 950.2 million compared to INR 967.01 million a year ago. Revenue was INR 957.34 million compared to INR 986.86 million a year ago. Net loss was INR 22.95 million compared to net income of INR 60.11 million a year ago. Basic loss per share from continuing operations was INR 0.49 compared to basic earnings per share from continuing operations of INR 1.27 a year ago. Diluted loss per share from continuing operations was INR 0.49 compared to diluted earnings per share from continuing operations of INR 1.27 a year ago.